Zobrazeno 1 - 10
of 298
pro vyhledávání: '"R. Hast"'
Autor:
Eva Kimby, Jan Liliemark, Magnus Björkholm, Astrid Gruber, Andreas Killander, Gunnar Juliusson, M. Järnmark, G. Grimfors, R. Hast, G. Gahrton
Publikováno v:
European Journal of Haematology. 55:19-23
Complex-binding of anthracyclines to DNA may increase their therapeutic efficacy. In a previous randomized trial patients with acute myelocytic leukaemia (AML) receiving combination chemotherapy including a DNA-bound doxorubicin preparation had a lon
Autor:
Håkan Mellstedt, Gunnar Juliusson, Eva Ösby, Bengt Simonsson, Bengt Smedmyr, C. Paul, B. Wadman, Bertil Johansson, Erik Svedmyr, H. Strander, Magnus Björkholm, M. Björeman, H. Gyllenhammar, Andreas Killander, Karl Merk, G. Brenning, G. Grimfors, G. Gahrton, A.-M. Stalfelt, Eva Kimby, Richard A. Lerner, M. Järnmark, A.-M. Udén, Anders Österborg, R. Hast
Publikováno v:
European Journal of Haematology. 43:124-128
A randomized study comparing melphalan/prednisone (M/P) therapy with MP + natural alpha-IFN in untreated patients with multiple myeloma stages II and III started April 1, 1986. By March 1989, 78 patients were evaluable in the MP group and 80 in the M
Publikováno v:
British Journal of Haematology. 51:531-539
Summary. Peripheral neuropathy has been described in malignant plasma cell dyscrasias such as multiple myeloma and Waldenstrom's macroglobulinaemia. Since it is not known whether the neuropathy is related to the plasma cell disorder or is a paramalig
Autor:
Ulf Tidefelt, C. Paul, Magnus Björkholm, I. Nilsson, M. Åström, R. Hast, Christina Löfgren, Dick Stockelberg, Bengt Simonsson, M. Hedenius, Jan Liliemark, R. Lerner, Stig Rödjer
Publikováno v:
British Journal of Haematology. 124:474-480
A total of 110 patients, aged 64 years or over, with de novo acute myeloid leukaemia (AML) and white blood cell counts
Publikováno v:
Scandinavian Journal of Gastroenterology. 39:1306-1309
A 57-year-old woman with AL-amyloid deposits in the heart, gastrointestinal tract and the liver developed ulcerative colitis, which was treated with glucocorticosteroids and 5-aminosalicylic acid, with good response. The AL-amyloidosis was successful
Autor:
Helene Hallböök, Anders Wahlin, Ingemar Winquist, Eva Löfvenberg, Olle Linder, Christer Paul, Eva Kimby, Jan Carneskog, Ingemar Turesson, Lars Vilén, Gunnar Grimfors, Richard Lerner, Karin Karlsson, Magnus Björkholm, Leif Stenke, Mats Linderholm, Ann-Marie Uden-Blome, Ulf Tidefelt, Bengt Simonsson, Thomas Ahlgren, Dick Stockelberg, R. Hast, Claes Malm, Bengt Smedmyr, P.G. Nilsson
Publikováno v:
British Journal of Haematology. 118:748-754
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia
Publikováno v:
Anti-Cancer Drugs. 8:42-47
The plasma pharmacokinetics of a second generation anthracycline derivative, idarubicin (Ida), have been studied in 17 patients with acute myelocytic leukemia (AML) and high risk features. The drug (10 mg/m2) was given in a randomized cross-over desi
Autor:
R. Hast, M. Kalin, M. Björkholm, G.T. Stiernstedt, G.C. Günther, B. Lönnqvist, P. Engervall, S. Ringertz, P. Ljungman
Publikováno v:
Journal of Chemotherapy. 8:382-386
Imipenem/cilastatin (I/C) monotherapy was used as salvage treatment in 55 neutropenic patients (58 fever episodes) after treatment failure on first-line antibiotic therapy. Successful antibiotic treatment was defined as eradication of all signs, symp
Publikováno v:
Journal of Internal Medicine. 229:381-386
Autor:
C, Löfgren, C, Paul, M, Aström, R, Hast, M, Hedenius, R, Lerner, J, Liliemark, I, Nilsson, S, Rödjer, B, Simonsson, D, Stockelberg, U, Tidefelt, M, Björkholm
Publikováno v:
British journal of haematology. 124(4)
A total of 110 patients, aged 64 years or over, with de novo acute myeloid leukaemia (AML) and white blood cell counts50 x 109/l were treated with 3 d of cytarabine 1 g/m2 twice daily, mitoxantrone 12 mg/m2 and etoposide 200 mg/m2, randomized with or